Inequitable conduct claims can add upwards of a million dollars to patent litigation, and adverse rulings can tank legal careers and corporate profits. The U.S. Court of Appeals for the Federal Circuit may finally be ready to consider whether the doctrine still works.
In November, the Federal Circuit is scheduled to hold an en banc hearing in Therasense Inc. v. Becton, Dickinson & Co. on whether to change the standards for proving inequitable conduct — when an applicant’s misstatements or omissions at a patent office invalidate a patent.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
